This work is licensed under the Creative Commons Attribution 4.0 International License.
Friedman JM. Neurofibromatosis 1. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® University of Washington, Seattle; 1993.FriedmanJMNeurofibromatosis 1In:AdamMPArdingerHHPagonRAeds.University of WashingtonSeattle1993Search in Google Scholar
Le C, Bedocs PM. Neurofibromatosis. In: StatPearls Publishing; 2021.LeCBedocsPMIn:StatPearls Publishing2021Search in Google Scholar
Denayer E, Legius E. Neurofibromatosis Type 1-Noonan Syndrome: What's the Link? Noonan Syndrome and Related Disorders - A Matter of Deregulated Ras Signaling 2009;17:128–137.DenayerELegiusENeurofibromatosis Type 1-Noonan Syndrome: What's the Link?20091712813710.1159/000164849Search in Google Scholar
Allanson JE, Hall JG, Van Allen MI. Noonan phenotype associated with neurofibromatosis. Am J Med Genet 1985;21(3):457–462.AllansonJEHallJGVan AllenMINoonan phenotype associated with neurofibromatosis198521345746210.1002/ajmg.1320210307Search in Google Scholar
Carey JC. Neurofibromatosis-Noonan syndrome. Am J Med Genet 1998;75(3):263–264.CareyJCNeurofibromatosis-Noonan syndrome199875326326410.1002/(SICI)1096-8628(19980123)75:3<263::AID-AJMG7>3.0.CO;2-RSearch in Google Scholar
Yapijakis C, Pachis N, Natsis S, Voumvourakis C. Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors? In Vivo 2016;30(3):315–320.YapijakisCPachisNNatsisSVoumvourakisCIs Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors?2016303315320Search in Google Scholar
Bertola DR, Pereira AC, Passetti F, et al. Neurofibromatosis–Noonan syndrome: Molecular evidence of the concurrence of both disorders in a patient. American Journal of Medical Genetics Part A 2005;136A(3):242–245.BertolaDRPereiraACPassettiFNeurofibromatosis–Noonan syndrome: Molecular evidence of the concurrence of both disorders in a patient2005136A324224510.1002/ajmg.a.30813Search in Google Scholar
Nyström AM, Ekvall S, Allanson J, et al. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1. Clin Genet 2009;76(6):524–534.NyströmAMEkvallSAllansonJNoonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1200976652453410.1111/j.1399-0004.2009.01233.xSearch in Google Scholar
Colley A, Donnai D, Evans DG. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet 1996;49(2):59–64.ColleyADonnaiDEvansDGNeurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis1996492596410.1111/j.1399-0004.1996.tb04328.xSearch in Google Scholar
De Luca A, Bottillo I, Sarkozy A, et al. NF1 Gene Mutations Represent the Major Molecular Event Underlying Neurofibromatosis-Noonan Syndrome. The American Journal of Human Genetics 2005;77(6):1092–1101.De LucaABottilloISarkozyANF1 Gene Mutations Represent the Major Molecular Event Underlying Neurofibromatosis-Noonan Syndrome20057761092110110.1086/498454Search in Google Scholar
Thiel C, Wilken M, Zenker M, et al. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. Am J Med Genet A 2009;149A(6):1263–1267.ThielCWilkenMZenkerMIndependent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome2009149A61263126710.1002/ajmg.a.32837Search in Google Scholar
Terzi Y, Kesikli B, Serdaroglu E, et al. Absence of exon 17 c.2970-2872delAAT mutation in Turkish NF1 patients with mild phenotype. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2011;27:2113–2116.TerziYKesikliBSerdarogluEAbsence of exon 17 c.2970-2872delAAT mutation in Turkish NF1 patients with mild phenotype2011272113211610.1007/s00381-011-1512-zSearch in Google Scholar
Incecik F, Hergüner ÖM, Alınç Erdem S, Altunbaşak Ş. Neurofibromatosis type 1 and cardiac manifestations. Turk Kardiyol Dern Ars 2015;43(8):714–716.IncecikFHergünerÖMAlınç ErdemSAltunbaşakŞNeurofibromatosis type 1 and cardiac manifestations201543871471610.5543/tkda.2015.27557Search in Google Scholar
Friedman JM, Arbiser J, Epstein JA, et al. Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force. Genet Med 2002;4(3):105–111.FriedmanJMArbiserJEpsteinJACardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force20024310511110.1097/00125817-200205000-00002Search in Google Scholar
Finley JL, Dabbs DJ. Renal vascular smooth muscle proliferation in neurofibromatosis. Hum Pathol 1988;19(1):107–110.FinleyJLDabbsDJRenal vascular smooth muscle proliferation in neurofibromatosis198819110711010.1016/S0046-8177(88)80325-3Search in Google Scholar
Sharma JB, Gulati N, Malik S. Maternal and perinatal complications in neurofibromatosis during pregnancy. Int J Gynaecol Obstet 1991;34(3):221–227.SharmaJBGulatiNMalikSMaternal and perinatal complications in neurofibromatosis during pregnancy199134322122710.1016/0020-7292(91)90353-7Search in Google Scholar
Rothner AD, Moodley M, Mientkiewicz L, Erenberg F. Congenital Heart Disease In Neurofibromatosis-1 (P2.225). Neurology 2015;84(14 Supplement).RothnerADMoodleyMMientkiewiczLErenbergFCongenital Heart Disease In Neurofibromatosis-1 (P2.225)20158414 SupplementSearch in Google Scholar
Lin AE, Birch PH, Korf BR, et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet 2000;95(2):108–117.LinAEBirchPHKorfBRCardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1200095210811710.1002/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0Search in Google Scholar
Tedesco M, Di salvo G, Natale F, et al. The heart in neurofibromatosis type 1: An echocardiographic study. American heart journal 2002;143:883–888.TedescoMDi salvoGNataleFThe heart in neurofibromatosis type 1: An echocardiographic study200214388388810.1067/mhj.2002.122121Search in Google Scholar
Fitzpatrick AP, Emanuel RW. Familial neurofibromatosis and hypertrophic cardiomyopathy. Heart 1988;60(3):247–251.FitzpatrickAPEmanuelRWFamilial neurofibromatosis and hypertrophic cardiomyopathy198860324725110.1136/hrt.60.3.247Search in Google Scholar
Jurko A, Minarik M, Minarikova E, Nagi A. Neurofibromatosis associated with hypertrophic cardiomyopathy. Saudi medical journal 2010;31:935–936.JurkoAMinarikMMinarikovaENagiANeurofibromatosis associated with hypertrophic cardiomyopathy201031935936Search in Google Scholar
Debonnaire P, De BO, De GF, Delanote J, Vandekerckhove Y, Muyldermans L. Multimodality Imaging of Cardiac Involvement in Neurofibromatosis. Journal of the American College of Cardiology 2011;57(17):e209–e209.DebonnairePDeBODeGFDelanoteJVandekerckhoveYMuyldermansLMultimodality Imaging of Cardiac Involvement in Neurofibromatosis20115717e209e20910.1016/j.jacc.2010.08.651Search in Google Scholar
Calcagni G, Limongelli G, D’Ambrosio A, et al. Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results. Int J Cardiol 2017;245:92–98.CalcagniGLimongelliGD’AmbrosioACardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results2017245929810.1016/j.ijcard.2017.07.068Search in Google Scholar
Linglart L, Gelb BD. Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment. Am J Med Genet C Semin Med Genet 2020;184(1):73–80.LinglartLGelbBDCongenital heart defects in Noonan syndrome: Diagnosis, management, and treatment20201841738010.1002/ajmg.c.31765Search in Google Scholar
Prendiville TW, Gauvreau K, Tworog-Dube E, et al. Cardiovascular disease in Noonan syndrome. Arch Dis Child 2014;99(7):629–634.PrendivilleTWGauvreauKTworog-DubeECardiovascular disease in Noonan syndrome201499762963410.1136/archdischild-2013-305047Search in Google Scholar
Kouz K, Lissewski C, Spranger S, et al. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation. Genet Med 2016;18(12):1226–1234.KouzKLissewskiCSprangerSGenotype and phenotype in patients with Noonan syndrome and a RIT1 mutation201618121226123410.1038/gim.2016.3227101134Search in Google Scholar
Colquitt JL, Noonan JA. Cardiac findings in Noonan syndrome on long-term follow-up. Congenit Heart Dis 2014;9(2):144–150.ColquittJLNoonanJACardiac findings in Noonan syndrome on long-term follow-up20149214415010.1111/chd.1210223750712Search in Google Scholar
2020 ESC Guidelines for the management of adult congenital heart disease | European Heart Journal | Oxford Academic.Search in Google Scholar
2018 ESC/ESH Guidelines for the management of arterial hypertension | European Heart Journal | Oxford Academic.Search in Google Scholar